Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...

Then they mapped single-cell lineage output to gene expression against a cDNA library ... s some sort of mechanism or quantitative association patterns that we haven’t appreciated in the field, which ...

Historically, cell lineage tracing studies have taken large pools of cells from mature tissues and inferred their origins retrospectively by staining the cells with vital dyes or transplanting ...

Broadwood Partners, L.P., a significant stakeholder in Lineage Cell Therapeutics, Inc. (NYSE:LCTX), has acquired a substantial amount of the company's common shares. The acquisition, valued at $6 ...

Lineage Cell Therapeutics (NYSEAMERICAN:LCTX – Free Report) had its price objective decreased by Maxim Group from $5.00 to $3.00 in a research report sent to investors on Friday morning ...